ASX:HMD

HeraMED (HMD) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
98,572 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HMD stock logo

About HeraMED Stock (ASX:HMD)

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.

HMD Stock News Headlines

Tech GIANT’s Plans to Revolutionize Crypto…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
HeraMED Limited (HMD.AX)
Tech GIANT’s Plans to Revolutionize Crypto…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
HeraMED Limited
See More Headlines
Receive HMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HeraMED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-4,500,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$205,434.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.13
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Ronald Peter Weinberger AIMM
    BSc (Hons), Ph.D., Executive Chairman
  • Mr. Ido Toronchik (Age 41)
    Chief Financial Officer
  • Henry Jordan
    Head of Investor Relations
  • Mr. Ariel Laden
    Vice President of Marketing
  • Mr. Keith Koby BSEET
    MBA, President of North America
  • Mr. Jonathan Hart B.Com. (Age 40)
    L.L.B., Company Secretary

This page (ASX:HMD) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners